Zevra Therapeutics Correlations

ZVRA Stock

8.01 0.06 0.75%

The current 90-days correlation between Zevra Therapeutics and Akebia Ther is 0.26 (i.e., Modest diversification). The correlation of Zevra Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Zevra Therapeutics Correlation With Market

Weak diversification

The correlation between Zevra Therapeutics and DJI is 0.34 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Zevra Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zevra Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade Zevra Stock refer to our How to Trade Zevra Stock guide.

Moving together with Zevra Stock

0.73	ELVN	Enliven Therapeutics	Pair Corr
0.71	CDIO	Cardio Diagnostics	Pair Corr
0.79	CRNX	Crinetics Pharmaceuticals	Pair Corr

Moving against Zevra Stock

0.7	WM	Waste Management	Pair Corr
0.7	GE	GE Aerospace	Pair Corr
0.63	PLX	Protalix Biotherapeutics	Pair Corr
0.58	LUCD	Lucid Diagnostics	Pair Corr
0.37	WMT	Walmart	Pair Corr
0.36	MLSS	Milestone Scientific Earnings Call This Week	Pair Corr
0.68	CSCO	Cisco Systems	Pair Corr
0.66	MMM	3M Company	Pair Corr
0.6	JNJ	Johnson Johnson	Pair Corr
0.6	IBM	International Business	Pair Corr
0.58	T	ATT Inc Earnings Call Tomorrow	Pair Corr
0.54	CVX	Chevron Corp	Pair Corr
0.53	JPM	JPMorgan Chase	Pair Corr
0.36	DD	Dupont De Nemours	Pair Corr
0.32	XOM	Exxon Mobil Corp	Pair Corr

Related Correlations Analysis

	RNAZ	FBIO	AKBA	TRVN	RVPH	GLUE	PMVP	PHVS	TYRA
RNAZ		-0.01	0.18	0.0	0.63	0.16	0.39	0.22	0.15	RNAZ
FBIO	-0.01		-0.04	0.0	0.57	0.35	0.6	0.63	0.62	FBIO
AKBA	0.18	-0.04		0.0	0.05	-0.09	-0.31	0.21	0.11	AKBA
TRVN	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	TRVN
RVPH	0.63	0.57	0.05	0.0		0.22	0.7	0.55	0.57	RVPH
GLUE	0.16	0.35	-0.09	0.0	0.22		0.47	0.11	-0.2	GLUE
PMVP	0.39	0.6	-0.31	0.0	0.7	0.47		0.4	0.4	PMVP
PHVS	0.22	0.63	0.21	0.0	0.55	0.11	0.4		0.73	PHVS
TYRA	0.15	0.62	0.11	0.0	0.57	-0.2	0.4	0.73		TYRA
	RNAZ	FBIO	AKBA	TRVN	RVPH	GLUE	PMVP	PHVS	TYRA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

TYRA	+ 0.73	PHVS
PMVP	+ 0.7	RVPH
RVPH	+ 0.63	RNAZ
PHVS	+ 0.63	FBIO
TYRA	+ 0.62	FBIO
PMVP	+ 0.6	FBIO

High negative correlations

PMVP	- 0.31	AKBA
TYRA	- 0.2	GLUE
GLUE	- 0.09	AKBA
AKBA	- 0.04	FBIO
FBIO	- 0.01	RNAZ
TYRA	- 0.0	TRVN

Risk-Adjusted Indicators

There is a big difference between Zevra Stock performing well and Zevra Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Zevra Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
RNAZ	10.83	(1.19)	0.00	(0.35)	0.00	0.00	45.13	(24.78)	94.32
FBIO	2.67	(0.11)	0.00	(0.65)	0.00	0.00	5.19	(4.87)	22.19
AKBA	3.58	0.62	0.07	0.14	5.85	(4.24)	7.25	(5.76)	61.90
TRVN	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
RVPH	5.07	(0.78)	0.00	(0.27)	0.00	0.00	11.05	(11.11)	39.67
GLUE	3.56	(0.22)	0.00	(0.26)	0.00	0.00	7.34	(7.69)	19.92
PMVP	1.83	(0.24)	0.00	(0.29)	0.00	0.00	4.41	(3.31)	16.42
PHVS	2.22	(0.28)	0.00	(1.00)	0.00	0.00	5.21	(3.86)	14.29
TYRA	2.59	(0.47)	0.00	0.64	0.00	0.00	7.08	(4.82)	15.45

Zevra Therapeutics Corporate Management

MD FFPM	Chief Officer	Profile
Rahsaan JD	Secretary Officer	Profile
Alison Peters	Chief Officer	Profile
Nichol Ochsner	Vice Communications	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC